FdaApplication
ANDA 209371
Identifiers
- fda_app_no: ANDA209371
Properties
| Property | Value |
|---|---|
| applicant_name | AUROBINDO PHARMA LTD |
| application_type | ANDA |
| approval_date | 2019-04-19 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| AMOXICILLIN AND CLAVULANATE POTASSIUM | AMOXICILLIN; CLAVULANATE POTASSIUM | 250MG/5ML;EQ 62.5MG BASE/5ML | FOR SUSPENSION;ORAL |
| AMOXICILLIN AND CLAVULANATE POTASSIUM | AMOXICILLIN; CLAVULANATE POTASSIUM | 125MG/5ML;EQ 31.25MG BASE/5ML | FOR SUSPENSION;ORAL |
2 products